InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: Crikker post# 283152

Saturday, 06/27/2020 2:34:21 PM

Saturday, June 27, 2020 2:34:21 PM

Post# of 426264
Crikker...

The state laws only mandate cheaper drugs get lower tiers..Less out of pocket payments...These can be substantial and if the physician insists on the more costly drug then generally he must have some rationale. I know because I am both a patient and a doctor. My PCP did file an appeal to Silver Scripts..MY Medicare Drug plan..But the drug plan denied the appeal.

The basis of their denial was that the R-I FDA Label was not approved and finalized until very late December.2019..And by that time the medicare formularies were closed until Nov 2020..These are insurance companies and they don't give Ice in the winter..The only label they were recognizing was the MARINE high trig label..

Right now Vascepa is patent protected for the R-I CVD event label..And no one..generics, drug plans, or states other than Amarin can sell the drug for the R-I indication without Amarin's consent..Infringing on Amarin's valid patents is a federal offence...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News